CEROID LIPOFUSCINOSIS, NEURONAL, 13
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis.
|
23297359 |
2013 |
CEROID LIPOFUSCINOSIS, NEURONAL, 13
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
CEROID LIPOFUSCINOSIS, NEURONAL, 13
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
CEROID LIPOFUSCINOSIS, NEURONAL, 13
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Pseudo-dominant inheritance of a novel CTSF mutation associated with type B Kufs disease.
|
25274848 |
2014 |
CEROID LIPOFUSCINOSIS, NEURONAL, 13
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease.
|
16508006 |
2006 |
CEROID LIPOFUSCINOSIS, NEURONAL, 13
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
De novo mutations in the genome organizer CTCF cause intellectual disability.
|
23746550 |
2013 |
CEROID LIPOFUSCINOSIS, NEURONAL, 13
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis.
|
23297359 |
2013 |
Dementia
|
0.110 |
Biomarker
|
disease |
BEFREE |
Although CTSF mutations account for a minority of cases of type B Kufs, CTSF screening should be considered in cases with early-onset dementia and may avoid the need for invasive biopsies.
|
23297359 |
2013 |
Dementia
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Bipolar Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry.
|
19416921 |
2009 |
Bipolar Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry.
|
19416921 |
2009 |
Depressive disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Mood swings
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebellar atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Adult Neuronal Ceroid Lipofuscinosis
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
We subsequently sequenced CTSF in 22 unrelated individuals with suspected recessive Kufs disease, and identified an additional patient with compound heterozygous mutations.
|
23297359 |
2013 |
Adult Neuronal Ceroid Lipofuscinosis
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Here, we report a sporadic case of Kufs disease type B with novel compound heterozygous mutations, a novel missense mutation c.977G>T (p.C326F) and a novel nonsense mutation c.416C>A (p.S139X), in the cathepsin-F gene.
|
29120254 |
2018 |
Adult Neuronal Ceroid Lipofuscinosis
|
0.030 |
Biomarker
|
disease |
BEFREE |
Our findings provide evidence that LIMP-2 represents an in vivo substrate of cathepsin-F with relevance for understanding the pathophysiology of type-B-Kufs-disease.
|
25576872 |
2015 |
Neuronal Ceroid-Lipofuscinoses
|
0.030 |
Biomarker
|
disease |
BEFREE |
CTSF encodes cathepsin F, a lysosomal cysteine protease, dysfunction of which is a highly plausible candidate mechanism for a storage disorder like ceroid lipofuscinosis.
|
23297359 |
2013 |
Neuronal Ceroid-Lipofuscinoses
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the gene encoding cathepsin-F (CTSF) have recently been associated with type-B-Kufs-disease, an adult form of neuronal ceroid-lipofuscinosis.
|
25576872 |
2015 |
Neuronal Ceroid-Lipofuscinoses
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Kufs disease type B (also termed CLN13), an adult-onset form of neuronal ceroid lipofuscinosis (NCL), is genetically heterogeneous and challenging to diagnose.
|
29120254 |
2018 |
Fabry Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Quantitative proteomics enabled the identification of >5,500 proteins in the cardiomyocyte proteome and secretome, and revealed accumulation of the lysosomal protein LIMP-2 and secretion of cathepsin F and HSPA2/HSP70-2 in FD.
|
31378672 |
2019 |
Presenile dementia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Although CTSF mutations account for a minority of cases of type B Kufs, CTSF screening should be considered in cases with early-onset dementia and may avoid the need for invasive biopsies.
|
23297359 |
2013 |
Diabetic Retinopathy
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Expression of cathepsin F and hepatocyte growth factor (HGF) genes was increased in ex vivo and organ-cultured DR corneas compared with normal corneas.
|
16186340 |
2005 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Six GC cell lines and 44 paired adjacent noncancerous and GC tissue samples were used to assess CTSF expression by quantitative polymerase chain reaction (qPCR).
|
28474574 |
2018 |